These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9366964)

  • 41. The effect of smoking on peripheral insulin sensitivity and plasma endothelin level.
    Borissova AM; Tankova T; Kirilov G; Dakovska L; Krivoshiev S
    Diabetes Metab; 2004 Apr; 30(2):147-52. PubMed ID: 15223986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of hyperinsulinaemia on the cardiovascular responses to graded hypovolaemia in normal and diabetic subjects.
    Scott AR; Bennett T; MacDonald IA
    Clin Sci (Lond); 1988 Jul; 75(1):85-92. PubMed ID: 3044666
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of glucose and insulin on transcapillary fluid absorption from the arm during lower body negative pressure in man.
    Olsen H; Groop L; Länne T
    Eur J Appl Physiol; 2003 Sep; 90(1-2):138-43. PubMed ID: 12851825
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increasing neopterin and decreasing endothelin-1 in plasma during insulin infusion in women.
    Gottsäter A; Rendell M; Anwaar I; Lindgärde F; Hulthén UL; Mattiasson I
    Scand J Clin Lab Invest; 1999 Oct; 59(6):417-24. PubMed ID: 10612552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Skeletal muscle blood flow is not a determinant of insulin resistance in essential hypertension.
    Hunter SJ; Harper R; Ennis CN; Sheridan B; Atkinson AB; Bell PM
    J Hypertens; 1997 Jan; 15(1):73-7. PubMed ID: 9050973
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction in insulin sensitivity following administration of the clinically used low-dose pressor, norepinephrine.
    Khoury N; McGill JB
    Diabetes Metab Res Rev; 2011 Sep; 27(6):604-8. PubMed ID: 21538777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physiological changes in insulin resistance in human pregnancy: longitudinal study with the hyperinsulinaemic euglycaemic clamp technique.
    Stanley K; Fraser R; Bruce C
    Br J Obstet Gynaecol; 1998 Jul; 105(7):756-9. PubMed ID: 9692417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recovery of 13C in breath from infused NaH13CO3 increases during euglycaemic hyperinsulinaemia.
    Reaich D; Graham KA; Cooper BG; Scrimgeour CM; Goodship TH
    Clin Sci (Lond); 1994 Oct; 87(4):415-9. PubMed ID: 7834993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous endothelin-1 and ventilatory sensitivity to hypoxia in humans.
    Talbot NP; Balanos GM; Robbins PA; Dorrington KL
    Adv Exp Med Biol; 2008; 605():57-62. PubMed ID: 18085247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mechanisms of insulin resistance in cancer associated malnutrition.
    Bennegård K; Lundgren F; Lundholm K
    Clin Physiol; 1986 Dec; 6(6):539-47. PubMed ID: 3539464
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The endothelium and endothelin: beyond vascular reactivity.
    Hassan W
    Ann Saudi Med; 2006; 26(5):343-5. PubMed ID: 17019103
    [No Abstract]   [Full Text] [Related]  

  • 52. Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Are there not some surrogate indexes lost in this story?
    Bastard JP; Rabasa-Lhoret R; Laville M; Disse E
    Diabetologia; 2015 Feb; 58(2):414-5. PubMed ID: 25341461
    [No Abstract]   [Full Text] [Related]  

  • 53. The effect of different doses of dimethylbiguanide (DMB) on liver blood flow, blood glucose and plasma immunoreactive insulin in anaesthetized rats.
    Ohnhaus EE; Berger W; Nars PW
    Biochem Pharmacol; 1978 Mar; 27(5):789-93. PubMed ID: 656118
    [No Abstract]   [Full Text] [Related]  

  • 54. Is coating of tubing required when endothelin-1 is infused intravenously?
    Vuurmans T; Koomans H; Boer P
    Nephrol Dial Transplant; 2003 Aug; 18(8):1677-8. PubMed ID: 12897117
    [No Abstract]   [Full Text] [Related]  

  • 55. Insulin resistance.
    Gans RO
    N Engl J Med; 1992 Feb; 326(9):646-7. PubMed ID: 1734263
    [No Abstract]   [Full Text] [Related]  

  • 56. [The primary remise after intravenous insulin exposure as a liver function test].
    HILLER E
    Klin Wochenschr; 1948 Jul; 26(27-28):428-30. PubMed ID: 18883345
    [No Abstract]   [Full Text] [Related]  

  • 57. Endothelin receptor antagonists in diabetic and non-diabetic chronic kidney disease.
    Ivković V; Bruchfeld A
    Clin Kidney J; 2024 Apr; 17(4):sfae072. PubMed ID: 38660120
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Advances and Perspectives in Relation to the Molecular Basis of Diabetic Retinopathy-A Review.
    Błaszkiewicz M; Walulik A; Florek K; Górecki I; Sławatyniec O; Gomułka K
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease.
    Smeijer JD; Kohan DE; Rossing P; Correa-Rotter R; Liew A; Tang SCW; de Zeeuw D; Gansevoort RT; Ju W; Lambers Heerspink HJ
    Cardiovasc Diabetol; 2023 Sep; 22(1):251. PubMed ID: 37716952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The association of aldosterone and endothelin-1 with incident diabetes among African Americans: The Jackson Heart Study.
    Joseph JJ; Kluwe B; Zhao S; Kline D; Nedungadi D; Brock G; Hsueh WA; Golden SH
    Endocr Metab Sci; 2023 Jun; 11():. PubMed ID: 37475850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.